The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sunitinib Drug Market Research Report 2025
Synopsis
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.
The global Sunitinib Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sunitinib Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sunitinib Drug.
Report Scope
The Sunitinib Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sunitinib Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sunitinib Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Segment by Type
12.5 mg Capsules
25 mg Capsules
37.5 mg Capsules
50 mg Capsules
Segment by Application
Kidney cancer
GIST
pNET
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sunitinib Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.
The global Sunitinib Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sunitinib Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sunitinib Drug.
Report Scope
The Sunitinib Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sunitinib Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sunitinib Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Segment by Type
12.5 mg Capsules
25 mg Capsules
37.5 mg Capsules
50 mg Capsules
Segment by Application
Kidney cancer
GIST
pNET
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sunitinib Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sunitinib Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 12.5 mg Capsules
1.2.3 25 mg Capsules
1.2.4 37.5 mg Capsules
1.2.5 50 mg Capsules
1.3 Market by Application
1.3.1 Global Sunitinib Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Kidney cancer
1.3.3 GIST
1.3.4 pNET
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sunitinib Drug Market Perspective (2019-2030)
2.2 Sunitinib Drug Growth Trends by Region
2.2.1 Global Sunitinib Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sunitinib Drug Historic Market Size by Region (2019-2024)
2.2.3 Sunitinib Drug Forecasted Market Size by Region (2025-2030)
2.3 Sunitinib Drug Market Dynamics
2.3.1 Sunitinib Drug Industry Trends
2.3.2 Sunitinib Drug Market Drivers
2.3.3 Sunitinib Drug Market Challenges
2.3.4 Sunitinib Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sunitinib Drug Players by Revenue
3.1.1 Global Top Sunitinib Drug Players by Revenue (2019-2024)
3.1.2 Global Sunitinib Drug Revenue Market Share by Players (2019-2024)
3.2 Global Sunitinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sunitinib Drug Revenue
3.4 Global Sunitinib Drug Market Concentration Ratio
3.4.1 Global Sunitinib Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sunitinib Drug Revenue in 2023
3.5 Sunitinib Drug Key Players Head office and Area Served
3.6 Key Players Sunitinib Drug Product Solution and Service
3.7 Date of Enter into Sunitinib Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sunitinib Drug Breakdown Data by Type
4.1 Global Sunitinib Drug Historic Market Size by Type (2019-2024)
4.2 Global Sunitinib Drug Forecasted Market Size by Type (2025-2030)
5 Sunitinib Drug Breakdown Data by Application
5.1 Global Sunitinib Drug Historic Market Size by Application (2019-2024)
5.2 Global Sunitinib Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sunitinib Drug Market Size (2019-2030)
6.2 North America Sunitinib Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sunitinib Drug Market Size by Country (2019-2024)
6.4 North America Sunitinib Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sunitinib Drug Market Size (2019-2030)
7.2 Europe Sunitinib Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sunitinib Drug Market Size by Country (2019-2024)
7.4 Europe Sunitinib Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sunitinib Drug Market Size (2019-2030)
8.2 Asia-Pacific Sunitinib Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sunitinib Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Sunitinib Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sunitinib Drug Market Size (2019-2030)
9.2 Latin America Sunitinib Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sunitinib Drug Market Size by Country (2019-2024)
9.4 Latin America Sunitinib Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sunitinib Drug Market Size (2019-2030)
10.2 Middle East & Africa Sunitinib Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sunitinib Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Sunitinib Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Sunitinib Drug Introduction
11.1.4 Pfizer Revenue in Sunitinib Drug Business (2019-2024)
11.1.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Sunitinib Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 12.5 mg Capsules
Table 3. Key Players of 25 mg Capsules
Table 4. Key Players of 37.5 mg Capsules
Table 5. Key Players of 50 mg Capsules
Table 6. Global Sunitinib Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Sunitinib Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Sunitinib Drug Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Sunitinib Drug Market Share by Region (2019-2024)
Table 10. Global Sunitinib Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Sunitinib Drug Market Share by Region (2025-2030)
Table 12. Sunitinib Drug Market Trends
Table 13. Sunitinib Drug Market Drivers
Table 14. Sunitinib Drug Market Challenges
Table 15. Sunitinib Drug Market Restraints
Table 16. Global Sunitinib Drug Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Sunitinib Drug Market Share by Players (2019-2024)
Table 18. Global Top Sunitinib Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sunitinib Drug as of 2023)
Table 19. Ranking of Global Top Sunitinib Drug Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Sunitinib Drug Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Sunitinib Drug Product Solution and Service
Table 23. Date of Enter into Sunitinib Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Sunitinib Drug Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Sunitinib Drug Revenue Market Share by Type (2019-2024)
Table 27. Global Sunitinib Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Sunitinib Drug Revenue Market Share by Type (2025-2030)
Table 29. Global Sunitinib Drug Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Sunitinib Drug Revenue Market Share by Application (2019-2024)
Table 31. Global Sunitinib Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Sunitinib Drug Revenue Market Share by Application (2025-2030)
Table 33. North America Sunitinib Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Sunitinib Drug Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Sunitinib Drug Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Sunitinib Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Sunitinib Drug Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Sunitinib Drug Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Sunitinib Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Sunitinib Drug Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Sunitinib Drug Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Sunitinib Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Sunitinib Drug Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sunitinib Drug Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sunitinib Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Sunitinib Drug Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Sunitinib Drug Market Size by Country (2025-2030) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Sunitinib Drug Product
Table 51. Pfizer Revenue in Sunitinib Drug Business (2019-2024) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Research Programs/Design for This Report
Table 54. Key Data Information from Secondary Sources
Table 55. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sunitinib Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Sunitinib Drug Market Share by Type: 2023 VS 2030
Figure 3. 12.5 mg Capsules Features
Figure 4. 25 mg Capsules Features
Figure 5. 37.5 mg Capsules Features
Figure 6. 50 mg Capsules Features
Figure 7. Global Sunitinib Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Sunitinib Drug Market Share by Application: 2023 VS 2030
Figure 9. Kidney cancer Case Studies
Figure 10. GIST Case Studies
Figure 11. pNET Case Studies
Figure 12. Sunitinib Drug Report Years Considered
Figure 13. Global Sunitinib Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Sunitinib Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Sunitinib Drug Market Share by Region: 2023 VS 2030
Figure 16. Global Sunitinib Drug Market Share by Players in 2023
Figure 17. Global Top Sunitinib Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sunitinib Drug as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Sunitinib Drug Revenue in 2023
Figure 19. North America Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Sunitinib Drug Market Share by Country (2019-2030)
Figure 21. United States Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Sunitinib Drug Market Share by Country (2019-2030)
Figure 25. Germany Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Sunitinib Drug Market Share by Region (2019-2030)
Figure 33. China Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Sunitinib Drug Market Share by Country (2019-2030)
Figure 41. Mexico Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Sunitinib Drug Market Share by Country (2019-2030)
Figure 45. Turkey Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Sunitinib Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Sunitinib Drug Business (2019-2024)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
